Royal Bank Of Canada Spring Works Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 70,362 shares of SWTX stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,362

Previous 67,654 4.0%

Holding current value

$2.55 Million

Previous $2.55 Million 11.54%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $86,764 - $115,794	2,708 Added 4.0%	70,362 $2.25 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $888,013 - $1.17 Million	24,626 Added 57.23%	67,654 $2.55 Million
Q1 2024 Nov 05, 2024	SELL	$36.5 - $52.5 $898,849 - $1.29 Million	-24,626 Reduced 36.4%	43,028 $2.12 Million
Q1 2024 May 15, 2024	SELL	$36.5 - $52.5 $614,368 - $883,680	-16,832 Reduced 28.12%	43,028 $2.12 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $250,273 - $492,089	13,214 Added 28.33%	59,860 $2.18 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $107,716 - $146,199	4,659 Added 11.1%	46,646 $1.08 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $331,276 - $468,080	14,310 Added 51.7%	41,987 $1.1 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $32,211 - $43,924	-1,290 Reduced 4.45%	27,677 $712,000
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $51,847 - $68,525	2,386 Added 8.98%	28,967 $753,000
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $34,872 - $57,388	1,447 Added 5.76%	26,581 $758,000
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $24,437 - $79,953	-1,331 Reduced 5.03%	25,134 $619,000
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $23,456 - $31,355	479 Added 1.84%	26,465 $1.49 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $548,137 - $779,938	10,284 Added 65.49%	25,986 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $796,596 - $1.12 Million	12,713 Added 425.33%	15,702 $996,000
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $201,608 - $255,948	2,989 New	2,989 $247,000

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.27B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Spring Works Therapeutics, Inc. Transaction History